Prevention of Recurrent UTI Using Vaginal Testosterone Versus Placebo Placebo
Recruiting
Phase 4
Interventional Study
Recurrent Urinary Tract Infection
Vaginal Atrophy
Postmenopausal Disorder
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 60 – 90
- Sex
- Female
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 100 (estimated)
- Sponsor
- Maimonides Medical Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Women over the age of 60 years have an estimated 10 to 15 % risk of recurrent urinary tract infections (UTI). This is believed to be due to hormonally induced changes in the vaginal flora associated with menopause. After menopause, there is a chemical changes in the vagina that may predispose to bacterial infections.
The role of vaginal estrogen creams to restore vaginal atrophy and prevent urina…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* 60-90 yo Female
* Postmenopausal
* Recurrent UTIs (three or more culture confirmed symptomatic episodes of UTI or two or more in the past 6 months).
* English Proficiency
* Unable or unwilling to use topical estrogen.
* Patients with history of or current endometrial or breast…
Contacts